Electronic Patient Reporting of Symptoms During Cancer Treatment

NCT03249090 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1197

Last updated 2025-01-14

Study results available
· View outcomes & findings →

Summary

The current study is designed to test nationally whether patients' outcomes and utilization of services can be improved through symptom monitoring via patient-reported outcomes between visits.

Conditions

Interventions

OTHER

Patient Self-Reporting of Symptoms

At baseline, CRAs will train patients to self-report symptoms and physical functioning weekly for up to a year, with a choice to do so online or via an automated telephone system. Whenever a concerning symptom is reported, an automated "email alert" notification will be sent to the site CRA. The CRA will forward the alert to the responsible clinical nurse (or other covering clinician) and CC the site's Nurse Champion. Within 72 hours, the CRA will document what action(s), if any, were taken by the nurse in response to the alert (entered by the CRA into a form in the PRO-Core system). A symptom report will be printed/generated by the site CRA whenever the patient has a clinic visit and will be given to the oncologist and nurse caring for the patient.

OTHER

Usual Care Delivery

Patients receive routine cancer care delivery with no additional systematic monitoring of symptoms

Sponsors & Collaborators

Principal Investigators

  • Ethan Basch, MD · University of North Carolina, Chapel Hill

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-10-30
Primary Completion
2022-03-30
Completion
2023-08-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03249090 on ClinicalTrials.gov